G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2006
11/09/2006	US20060252087 Recovery of rare cells using a microchannel apparatus with patterned posts
11/09/2006	US20060252082 Predicting treatment response in cancer subjects
11/09/2006	US20060252076 SIR2 activity
11/09/2006	US20060252066 Compositions and methods for the therapy and diagnosis of kidney cancer
11/09/2006	US20060252065 Surface enhanced Raman spectroscopy (SERS) systems, substrates, fabrication thereof, and methods of use thereof
11/09/2006	US20060252060 Direct multiplex characterization of genomic DNA
11/09/2006	US20060252057 Lung cancer prognostics
11/09/2006	US20060252054 Methods and compositions for detecting non-hematopoietic cells from a blood sample
11/09/2006	US20060252053 Drug screening; ability to block apoptosis and promote cell growth and transformation; cancer; inhibition of caspase-7 polypeptide
11/09/2006	US20060252052 Novel druggable regions in the dengue virus envelope glycoprotein and methods of using the same
11/09/2006	US20060252049 Growth-promoting and immunizing subcutaneous implant
11/09/2006	US20060252048 Method for testing ghrelin release
11/09/2006	US20060252047 Device and method for analysis of samples using a combined sample treatment and sample carrier device
11/09/2006	US20060252046 Plasma polymerisation methods for the deposition of chemical gradients and surfaces displaying gradient of immobilised biomolecules
11/09/2006	US20060252044 Biochip and biochip kit, and method of producing the same and method of using the same
11/09/2006	US20060252042 Methods of treatment of feeding disorders or disorders of glucose uptake and for modifying metabolism and identifying therapeutic reagents therefor
11/09/2006	US20060252037 Expression vector comprising antisense nuclelotide sequence which decrease exxpression from kinase suppressor of RAS (KRAS) for use in the treatment and prevention of cell proliferative disorders
11/09/2006	US20060252036 Alteration of rab38 function to modulate mammalian pigmentation
11/09/2006	US20060252035 Using sphingosine kinase-2 as tool in identifying modulators for use in treatment of cell proliferative disorders
11/09/2006	US20060252034 Novel protein containing ring finger domaine r1p4
11/09/2006	US20060252030 Fabrication of carbohydrate chips by immobilizing unmodified carbohydrates on derivatized solid surfaces, and their uses
11/09/2006	US20060251709 applying a lipid solution to a membrane formation opening provided in a plate portion of a membrane support, that is in contact with aqueous solution, then sandwiching the lipid solution between the aqueous solution and the support layer whose surface is hydrophilic
11/09/2006	US20060251693 Sugar binding surface
11/09/2006	US20060251668 Tumor-specific recognition molecules
11/09/2006	US20060251666 Cancer antigens and utilization thereof
11/09/2006	US20060251664 Method for the identification of epitopes related to immunogenicity in biopharmaceuticals
11/09/2006	US20060251662 diagnosing the presence of a multiple myeloma tumor in a mammal; antitumor agents; identify polypeptides, cell membrane-associated, secreted or intracellular polypeptides whose expression is specifically limited to only a single (or very limited number of different) tissue type(s)
11/09/2006	US20060251659 Method for screening molecules that restore NOD1 activity in cells containing an NOD2 mutation that reduces or eliminates NOD1 activity
11/09/2006	US20060251655 Antibody against enzyme specifically cleaving von villebrand factor and assay system using the same
11/09/2006	US20060251651 Antagonist and agonist which bind to a strong binding site of chemokine receptor
11/09/2006	US20060251648 Nucleotide sequences coding transport protein for use in identifying modulators for treatment of pain; flavor enhancement
11/09/2006	US20060251644 or an antigen binding fragment comprising variable light chain region and heavy chain peptides, directed against isotypic determinants of immunoglobulin E (IgE), useful for diagnostics, prophylaxis and treatment of disease such as asthma, rhinitis, eczema, urticaria. dermatitis or food allergies
11/09/2006	US20060251642 Modulation of stem cells using zinc finger proteins
11/09/2006	US20060251635 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them
11/09/2006	US20060251545 Process and system for purifying gases
11/09/2006	US20060250930 Optical discs for measuring analytes
11/09/2006	US20060250604 Blood analyzer, sample analyzer, and flow cytometer
11/09/2006	US20060250130 Contamination estimation using fluid analysis models
11/09/2006	US20060250080 Light-emitting device
11/09/2006	US20060249577 Hand-held laser scanning device for scanning a product item
11/09/2006	US20060248948 Method for determining of the formation factor for a subterranean deposit from measurements on drilling waste removed therefrom
11/09/2006	DE19724014B4 Verfahren und Einrichtung zum Bestimmen des Ladungsnullpunkts von elektrisch geladenen kolloidalen und/oder suspendierten Teilchen Method and device for determining the zero point charge of electrically charged colloidal and / or suspended particles
11/09/2006	DE102005022823A1 Sample carrier with an ultraphobic surface, useful for isolating and analyzing biomolecules, has an affinity zone and a waste zone and/or a zone covered with a matrix-assisted laser desorption/ionization matrix
11/09/2006	DE102005021626A1 Passive open and ground water sampling procedure mounts sampler or detector strips on rotating drive
11/09/2006	DE102005021509A1 Tissue culture allowing production of spaced vessels, vessel dressings or hollow organs involves colonization of a biodegradable or permanent carrier
11/09/2006	DE102005020985A1 Verfahren zur Probeentnahme sowie Probeentnahmevorrichtung Sampling procedures and sampling device
11/09/2006	DE102005020875A1 Medical procedure for detection or pure production of tumor suppressor for diagnosis and/or prognosis of cancer, comprises immobilizing insulin or structurally related insulin molecule
11/09/2006	DE102005020776A1 Test system for determining risk or influences to health in human or animal, by using textile in contact with perfused skin and detecting penetrated or permeated substances
11/09/2006	DE102005020384A1 Spektroskopisches Verfahren zum Nachweis von Analyten A spectroscopic method for the detection of analytes
11/09/2006	DE102005020297A1 Device for testing disc material with radiation source has radiation source and radiation detector, which are arranged on opposite sides with respect to disc material
11/09/2006	DE102005019191A1 Detektion der Abdichtung mittels Rauschanalyse Detection of the seal by means of noise analysis
11/09/2006	DE102005015832A1 Use of receptor multimerization epitope (RME) of advanced glycation end product receptor (AGER) as immunogen, useful for preparing antibodies for diagnosis and treatment of e.g. spinal injuries or diabetic complications
11/09/2006	DE102005011739A1 Verfahren zur Bestimmung bzw. Überprüfung der Durchhärtung eines mit Druckfarbe bedruckten Objektes Method for determining or reviewing the curing of printed with ink object
11/09/2006	DE102005010096B3 Assay mit osmotisch induzierter Abtrennung und Anreicherung hochmolekularer nachzuweisender Substanzen und fluidisches Mikrosystem zu seiner Durchführung Assay with osmotically induced separation and enrichment of high molecular weight substances to be detected and fluidic microsystem for its implementation
11/09/2006	CA2609640A1 Cellular assay method for identifying pkc-0 inhibitors
11/09/2006	CA2607586A1 Synthetic and standardized prion infectuous material, and uses thereof as an infecting inoculum
11/09/2006	CA2607533A1 Xenograft tissue control for histology
11/09/2006	CA2607530A1 New labelling strategies for the sensitive detection of analytes
11/09/2006	CA2607524A1 Agent for prophylaxis and treating of pancreatitis
11/09/2006	CA2607341A1 Diagnosis and treatment of endometriosis
11/09/2006	CA2607327A1 Antibodies against histone modifications for clinical diagnosis and prognosis of cancer
11/09/2006	CA2607234A1 Method for identifying modulators of noah10 useful for treating alzheimer's disease
11/09/2006	CA2607200A1 System and method for characterization of a particle flow
11/09/2006	CA2607185A1 Intracellular active agents
11/09/2006	CA2607133A1 Composition and method for diagnosing esophageal cancer and metastasis of esophageal cancer
11/09/2006	CA2607095A1 Compositions and methods for modulating dopamine neurotransmission
11/09/2006	CA2607086A1 System for rapid analysis of microbiological materials in liquid samples
11/09/2006	CA2607060A1 Selecting, culturing and creating lineage committed hematopoietic stem cells
11/09/2006	CA2606962A1 Assays for diagnosis of tuberculosis and uses thereof
11/09/2006	CA2606906A1 Fluorogenic measurment of thrombin activity in a thin layer of whole blood
11/09/2006	CA2606876A1 Fluorescent proteins and uses thereof
11/09/2006	CA2606815A1 Polymer conjugate enhanced bioassays
11/09/2006	CA2606721A1 Detection of carbohydrate biomarkers
11/09/2006	CA2606664A1 Detection of ortho-diamine residues in analytes containing residual cyclizing agents
11/09/2006	CA2606506A1 Superantibody synthesis and use in detection, prevention and treatment of disease
11/09/2006	CA2606489A1 Method for identification of compound having antidepressant effect
11/09/2006	CA2606479A1 Nogo receptor functional motifs and peptide mimetics related thereto and methods of using the same
11/09/2006	CA2606450A1 Anti-platelet membrane glycoprotein vi monoclonal antibody
11/09/2006	CA2606341A1 Genemap of the human genes associated with crohn's disease
11/09/2006	CA2606177A1 Novel polypeptide and use thereof
11/09/2006	CA2606169A1 Immunological assay for plasmin-digested products of stabilized fibrin
11/09/2006	CA2606162A1 Peptide having antianxiety activity and screening method therefor
11/09/2006	CA2605876A1 Method for measuring consistency, chopper structure, and consistency meter
11/09/2006	CA2605809A1 Spectroscopic method for the detection of analytes
11/09/2006	CA2605329A1 Method for determination of cholesterol in high-density lipoprotein
11/09/2006	CA2605152A1 Method for determining the stage of ulcerative colitis or interstitial pneumonia and reagent kit thereof
11/09/2006	CA2605011A1 Process for characterization of the transactivation and transrepression activity of glucocorticoid receptor ligands in primary immune cells
11/09/2006	CA2604608A1 Antibody directed against gastrin-releasing peptide precursor and use thereof
11/09/2006	CA2595277A1 Method for diagnosing multiple sclerosis
11/08/2006	EP1720015A1 Process for producing biochip, probe solution, and biochip
11/08/2006	EP1720014A1 Method of judging the extent of vasculopathy
11/08/2006	EP1720013A2 Multiphase fluid characterization
11/08/2006	EP1720008A1 Carbon monoxide sensor and method for sensing carbon monoxide
11/08/2006	EP1719875A2 Pyrolytic oil-productivity index method for predicting reservoir rock and oil characteristics
11/08/2006	EP1719819A1 Method for screening h-type rnase inhibitor of reverse transcriptase
11/08/2006	EP1719779A2 Antibodies against Matin
11/08/2006	EP1719777A1 Electrochemically active ligand for sequence-specific detection of double-stranded nucleic acid molecule
11/08/2006	EP1719774A2 Preventive or therapeutic agent for diabetic maculopathy
11/08/2006	EP1719525A1 NUCLEAR TRANSFER PROMOTER FOR Cdc42 PROTEIN AND METHOD OF SCREENING THE SAME
11/08/2006	EP1719524A1 Nuclear transfer promoter for rac protein and method of screening the same

1 ... 1784 1785 1786 1787 1788 1789 1790 1791 1792 1793 1794 1795 1796 1797 1798 1799 1800 1801 1802 1803 1804 ... 3937